BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37268494)

  • 1. Characteristics of Patients With Second Primary Lung Cancer Following Breast Cancer: A Retrospective Descriptive Study.
    Wang KY; Lee CS; Vempati P; Sharma R; Kohn N; Seetharamu N
    Clin Lung Cancer; 2023 Sep; 24(6):e198-e204. PubMed ID: 37268494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Single-Center Retrospective Study of Patients with Double Primary Cancers: Breast Cancer and EGFR-Mutant Non-Small Cell Lung Cancer.
    Moran T; Quiroga V; Cirauqui B; Vila L; Gil-Moreno M; Carcereny E; Margeli M; Muñoz-Marmol A; Mate JL; Velarde JM; Molina MA; Rosell R
    Oncol Res Treat; 2019; 42(3):107-114. PubMed ID: 30799393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-small-cell lung cancer after breast cancer: a population-based study of clinicopathologic characteristics and survival outcomes in 3529 women.
    Milano MT; Strawderman RL; Venigalla S; Ng K; Travis LB
    J Thorac Oncol; 2014 Aug; 9(8):1081-90. PubMed ID: 25157761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer.
    Kaufman EL; Jacobson JS; Hershman DL; Desai M; Neugut AI
    J Clin Oncol; 2008 Jan; 26(3):392-8. PubMed ID: 18202415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated subsequent lung cancer after post-operative radiotherapy for breast cancer.
    Basse C; Ancel J; Massiani MA; Bonté PE; Beaulaton C; Beaucaire-Danel S; Milder M; Cao K; Daniel C; Du Rusquec P; Sablin MP; Kirova Y; Sage E; Beddok A; Girard N
    Lung Cancer; 2023 Aug; 182():107295. PubMed ID: 37442059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic features of breast cancers diagnosed in women treated with prior radiation therapy for Hodgkin lymphoma: Results from a population-based cohort.
    Wong SM; Ajjamada L; Weiss AC; Prakash I; Skamene S; Boileau JF; Pollak MN; Basik M
    Cancer; 2022 Apr; 128(7):1365-1372. PubMed ID: 34919263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
    Wu GX; Nelson RA; Kim JY; Raz DJ
    Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological features, risk and survival in lung cancer survivors with therapy-related acute myeloid leukaemia.
    Wang H; Yin Y; Wang R; Huang J; Xue H; Cheng Y; Zhang L; Chen C
    BMC Cancer; 2020 Nov; 20(1):1081. PubMed ID: 33172389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Second Primary Lung Cancer After Low-Dose Computed Tomography vs Chest Radiography Screening in Survivors of Head and Neck Cancer: A Secondary Analysis of a Randomized Clinical Trial.
    Cramer JD; Grauer J; Sukari A; Nagasaka M
    JAMA Otolaryngol Head Neck Surg; 2021 Dec; 147(12):1071-1078. PubMed ID: 34709369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second Primary Non-Small-Cell Lung Cancer After Head and Neck Cancer: A Population-Based Study of Clinical and Pathologic Characteristics and Survival Outcomes in 3597 Patients.
    Budnik J; DeNunzio NJ; Singh DP; Milano MT
    Clin Lung Cancer; 2020 May; 21(3):195-203. PubMed ID: 30914310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice.
    Faehling M; Schwenk B; Kramberg S; Fallscheer S; Leschke M; Sträter J; Eckert R
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):2059-2066. PubMed ID: 30062488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer in female survivors of Wilms tumor: a report from the national Wilms tumor late effects study.
    Lange JM; Takashima JR; Peterson SM; Kalapurakal JA; Green DM; Breslow NE
    Cancer; 2014 Dec; 120(23):3722-30. PubMed ID: 25348097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and sociodemographic risk factors associated with the development of second primary cancers among postmenopausal breast cancer survivors.
    Bailey S; Ezratty C; Mhango G; Lin JJ
    Breast Cancer; 2023 Mar; 30(2):215-225. PubMed ID: 36316601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation Therapy for Invasive Breast Cancer Increases the Risk of Second Primary Lung Cancer: A Nationwide Population-Based Cohort Analysis.
    Huang YJ; Huang TW; Lin FH; Chung CH; Tsao CH; Chien WC
    J Thorac Oncol; 2017 May; 12(5):782-790. PubMed ID: 28214559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung cancer and other second neoplasms after treatment of Hodgkin lymphoma.
    Almagro-Casado E; Sánchez A; Cantos B; Salas C; Pérez-Callejo D; Provencio M
    Clin Transl Oncol; 2016 Jan; 18(1):99-106. PubMed ID: 26530956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of a second primary lung cancer after a first invasive breast cancer according to estrogen receptor status.
    Schonfeld SJ; Curtis RE; Anderson WF; Berrington de González A
    Cancer Causes Control; 2012 Oct; 23(10):1721-8. PubMed ID: 22918549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database.
    Li S; Yang J; Shen Y; Zhao X; Zhang L; Wang B; Li P; Wang Y; Yi M; Yang J
    BMC Public Health; 2019 Nov; 19(1):1592. PubMed ID: 31783815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation-Associated Secondary Malignancies in BRCA Mutation Carriers Treated for Breast Cancer.
    Schlosser S; Rabinovitch R; Shatz Z; Galper S; Shahadi-Dromi I; Finkel S; Jacobson G; Rasco A; Friedman E; Laitman Y; Evron E; Bernstein R; Weiss I; Sklair-Levy M; Ben-David MA
    Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):353-359. PubMed ID: 32084523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Clinicopathologic and Molecular Tumor Features With Recurrence in Resected Early-Stage Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer.
    Saw SPL; Zhou S; Chen J; Lai G; Ang MK; Chua K; Kanesvaran R; Ng QS; Jain A; Tan WL; Rajasekaran T; Lim DWT; Tan A; Fong KW; Takano A; Cheng XM; Lim KH; Koh T; Ong BH; Tan EH; Toh CK; Skanderup AJ; Tan SH; Tan DSW
    JAMA Netw Open; 2021 Nov; 4(11):e2131892. PubMed ID: 34739062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological characteristics and prognosis of breast cancer patients with lung cancer: A study based on 19,807 breast cancer patients.
    Liu JZ; Zhang WF; Ren XF; Zhang G; Yang C; Zhang S; Zhang XM; Liu YJ
    Neoplasma; 2022 Mar; 69(2):484-490. PubMed ID: 35263992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.